Newsletters

Catch up on our latest newsletters - curated updates, insights, and news delivered to you.

Restoration or Substitution: The Distinction that Determines a BCI Program's Market

Implantable brain-computer interfaces are drawing record investment, and most diligence still focuses on engineering. But the same hardware is being used for two different purposes. Some devices bypass a lost pathway, and others try to repair a damaged one. In this issue, we explain why engineering metrics predict outcomes for the first kind but not the second. We also argue that for restorative programs in stroke and TBI, patient selection is the variable that decides whether a trial succeeds.

Read the full brief →

Issue No. 3

Issue No. 2

What's being published, what regulators are signaling, and what it means for neuroscience investors and drug developmers

Selected publications, regulatory developments, and industry events — with independent scientific interpretation from the SignalNeuro Partners team

News & Insights

Issue No. 1